123 related articles for article (PubMed ID: 38654633)
1. A detailed density functional theory exploration of the photodissociation mechanism of ruthenium complexes for photoactivated chemotherapy.
Belletto D; Ponte F; Mazzone G; Sicilia E
Dalton Trans; 2024 May; 53(19):8243-8253. PubMed ID: 38654633
[TBL] [Abstract][Full Text] [Related]
2. Photosubstitution in a trisheteroleptic ruthenium complex inhibits conjunctival melanoma growth in a zebrafish orthotopic xenograft model.
Chen Q; Cuello-Garibo JA; Bretin L; Zhang L; Ramu V; Aydar Y; Batsiun Y; Bronkhorst S; Husiev Y; Beztsinna N; Chen L; Zhou XQ; Schmidt C; Ott I; Jager MJ; Brouwer AM; Snaar-Jagalska BE; Bonnet S
Chem Sci; 2022 Jun; 13(23):6899-6919. PubMed ID: 35774173
[No Abstract] [Full Text] [Related]
3. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
Li A; Turro C; Kodanko JJ
Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
[TBL] [Abstract][Full Text] [Related]
4. Preparation, stability, and photoreactivity of thiolato ruthenium polypyridyl complexes: Can cysteine derivatives protect ruthenium-based anticancer complexes?
van Rixel VH; Busemann A; Göttle AJ; Bonnet S
J Inorg Biochem; 2015 Sep; 150():174-81. PubMed ID: 26187140
[TBL] [Abstract][Full Text] [Related]
5. To cage or to be caged? The cytotoxic species in ruthenium-based photoactivated chemotherapy is not always the metal.
Cuello-Garibo JA; Meijer MS; Bonnet S
Chem Commun (Camb); 2017 Jun; 53(50):6768-6771. PubMed ID: 28597879
[TBL] [Abstract][Full Text] [Related]
6. Selective Preparation of a Heteroleptic Cyclometallated Ruthenium Complex Capable of Undergoing Photosubstitution of a Bidentate Ligand.
Cuello-Garibo JA; James CC; Siegler MA; Hopkins SL; Bonnet S
Chemistry; 2019 Jan; 25(5):1260-1268. PubMed ID: 30318782
[TBL] [Abstract][Full Text] [Related]
7. Influence of the Steric Bulk and Solvent on the Photoreactivity of Ruthenium Polypyridyl Complexes Coordinated to l-Proline.
Cuello-Garibo JA; Pérez-Gallent E; van der Boon L; Siegler MA; Bonnet S
Inorg Chem; 2017 May; 56(9):4818-4828. PubMed ID: 28406644
[TBL] [Abstract][Full Text] [Related]
8. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
9. Electronic and Photophysical Properties of [Re (L)(CO)3(phen)](+) and [Ru(L)2(bpy)2](2+) (L = imidazole), Building Units for Long-Range Electron Transfer in Modified Blue Copper Proteins.
Fumanal M; Daniel C
J Phys Chem A; 2016 Sep; 120(35):6934-43. PubMed ID: 27504895
[TBL] [Abstract][Full Text] [Related]
10. New Ru(II) complexes for dual photoreactivity: ligand exchange and (1)O2 generation.
Knoll JD; Albani BA; Turro C
Acc Chem Res; 2015 Aug; 48(8):2280-7. PubMed ID: 26186416
[TBL] [Abstract][Full Text] [Related]
11. Ligand Rigidity Steers the Selectivity and Efficiency of the Photosubstitution Reaction of Strained Ruthenium Polypyridyl Complexes.
Hakkennes MLA; Meijer MS; Menzel JP; Goetz AC; Van Duijn R; Siegler MA; Buda F; Bonnet S
J Am Chem Soc; 2023 Jun; 145(24):13420-13434. PubMed ID: 37294954
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of ligand photodissociation in photoactivable [Ru(bpy)2L2]2+ complexes: a density functional theory study.
Salassa L; Garino C; Salassa G; Gobetto R; Nervi C
J Am Chem Soc; 2008 Jul; 130(29):9590-7. PubMed ID: 18588292
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium-based PACT agents based on bisquinoline chelates: synthesis, photochemistry, and cytotoxicity.
Busemann A; Flaspohler I; Zhou XQ; Schmidt C; Goetzfried SK; van Rixel VHS; Ott I; Siegler MA; Bonnet S
J Biol Inorg Chem; 2021 Sep; 26(6):667-674. PubMed ID: 34378103
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium Pyrazole Complexes: A Family of Highly Active Metallodrugs for Photoactivated Chemotherapy.
Hirahara M; Iwamoto A; Teraoka Y; Mizuno Y; Umemura Y; Uekita T
Inorg Chem; 2024 Jan; 63(4):1988-1996. PubMed ID: 38215027
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence singlet oxygen formation vs. ligand substitution for light-activated ruthenium anticancer compounds.
Papish ET; Oladipupo OE
Curr Opin Chem Biol; 2022 Jun; 68():102143. PubMed ID: 35483128
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium(II) Polypyridyl-Based Photocages for an Anticancer Phytochemical Diallyl Sulfide: Comparative Dark and Photoreactivity Studies of Caged and Precursor Uncaged Complexes.
Mishra R; Saha A; Chatterjee P; Bhattacharyya A; Patra AK
Inorg Chem; 2023 Nov; 62(46):18839-18855. PubMed ID: 37930798
[TBL] [Abstract][Full Text] [Related]
17. Physical, photophysical and structural properties of ruthenium(II) complexes containing a tetradentate bipyridine ligand.
Kirgan RA; Witek PA; Moore C; Rillema DP
Dalton Trans; 2008 Jun; (24):3189-98. PubMed ID: 18688417
[TBL] [Abstract][Full Text] [Related]
18. Unravelling the role of [Ru(bpy)
Paul L; Enkhbold K; Robinson S; Aye TT; Chung Y; Harrison DP; Pollock JA; Norris MR
J Inorg Biochem; 2022 Oct; 235():111930. PubMed ID: 35841722
[TBL] [Abstract][Full Text] [Related]
19. Mixed-ligand complexes of ruthenium(II) containing new photoactive or electroactive ligands: synthesis, spectral characterization and DNA interactions.
Ghosh T; Maiya BG; Samanta A; Shukla AD; Jose DA; Kumar DK; Das A
J Biol Inorg Chem; 2005 Aug; 10(5):496-508. PubMed ID: 15981005
[TBL] [Abstract][Full Text] [Related]
20. Ligand-selective photodissociation from [Ru(bpy)(4AP)4]2+: a spectroscopic and computational study.
Salassa L; Garino C; Salassa G; Nervi C; Gobetto R; Lamberti C; Gianolio D; Bizzarri R; Sadler PJ
Inorg Chem; 2009 Feb; 48(4):1469-81. PubMed ID: 19149466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
